Attendees can participate in person and virtual through live streaming. From 14-16 June 2023 the EHA2023 Thematic Days will take place all virtual. EHA is a highly valued HARMONY and HARMONY PLUS Partner.
Co-operative working groups, hospitals and academic institutions are invited to collaborate and contribute data to the HARMONY Alliance. Le'ts connect and explain more during EHA2023, please send us an email ito set up an appointment with HARMONY Experts, mail to communications@harmony-alliance.eu
Learn and interact about the impact of Real World Data and Real-World Evidence on research and clinical care now and in the future. Includes latest achievements of the HARMONY Alliance and plans for the future.
We are proud to present the following approved abstracts:
Click here to find the links to the abstract and details about the presentations on site >
Date/time: Sunday, 11 June from 09:45-10:45 hrs | s238 | Hall Goldman
Our session is dedicated to the impact of Real-World Data and Real-World Evidence on research and clinical care, featuring:
After more than six years of joint work, the HARMONY Alliance reaped the benefits of building a research infrastructure with the best brains of European blood cancer research. Through a wide variety of collaborative activities, HARMONY has truly demonstrated the power of Big Data to improve the treatment of Hematologic Malignancies (HMs). In HARMONY research projects, scientists and physicians team up to produce novel insights into the biology of HMs. They run new algorithms and perform analyses on the thousands of anonymized data sets stored in the HARMONY Big Data Platform to detect relevant patterns. The results may be used to identify high-risk patients with greater reliability and to guide treatment choices in the future.
#bigdataforbloodcancer: Accelerating Better and Faster Treatment for Patients with Hematologic Malignancies.
#bigdataforbloodcancer: Accelerating Better and Faster Treatment for Patients with Hematologic Malignancies.
The HARMONY Alliance (HARMONY and HARMONY PLUS) is a public-private European Network of Excellence for Big Data in Hematology. Our mission is to unlock and spread valuable knowledge on hematologic malignancies (blood cancers) among a large number of stakeholders, with the goal to harness and mine Big Data to speed up the development of improved treatments for patients and more effective treatment strategies. HARMONY is a partnership with more than 140 organizations such as hospitals, research institutes, patient organizations, pharmaceutical companies, regulatory agencies, IT companies, and medical network and associations such as EHA. Together, they have developed the HARMONY Big Data Platform and the HARMONY Datalake, which contains anonymized data records from tens of thousands of blood cancer patients. This unique research infrastructure, with advanced big data analytic and AI tools, is being used to accelerate the development of more effective treatments for patients with hematologic malignancies (blood cancers).
HARMONY has identified more than 156,000 patient datasets and has transferred more than 73,000 datasets into the HARMONY Big Data Platform. Careful procedures have been installed to ensure the anonymization and quality of the data. In addition, HARMONY data scientists have developed sophisticated methods for data harmonization and analysis. Dedicated Research Project teams are currently using the Big Data Platform to answer critical research questions that cannot be addressed with other methods.
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
